The Food and Drug Administration (FDA) says a previously announced recall of certain bags of Lay’s potato chips in Oregon and Washington now falls into “Class I” status, its highest risk
The Food and Drug Administration has issued a Class 1 alert after Frito-Lay issued a recall for bags of Lay’s potato chips sold in Oregon and Washington.
The FDA classified recalled Lay's Classic Potato Chips in two states under a Class 1 recall, meaning consumption could be fatal for people with a milk allergy.
The Lay’s potato chips recall for undeclared milk was upgraded to the FDA’s highest risk level. Find out what this means for consumers and food safety in 2025.
Federal health authorities have upgraded their recall of 13-ounce bags of Frito-Lay potato chips over fears that consuming the products, which may contain undeclared milk, could potentially be fatal. Last month, the Food and Drug Administration announced that Frito-Lay was voluntarily recalling a limited batch of products.
The FDA first announced on December 18, 2024, that Frito-Lay issued a recall on a “limited number” of the 13 oz bags of chips. These Lay’s Classic Potato Chips bags were recalled because they “may contain undeclared milk ,” which Frito-Lay learned “after being alerted through a consumer contact.”
A party bag of potato chips from Lay's was recalled in December, and has just been given the highest recall classification from the FDA.
Frito-Lay has recalled over 6,000 bags of Lay’s Classic Potato Chips due to undeclared milk, which poses a serious risk to individuals with dairy allergies. The FDA upgraded the recall to Class I—the highest risk level—after determining the chips could cause life-threatening allergic reactions,
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
The problem ingredient identified was "undeclared milk," which poses a risk to those with severe sensitivities or allergies.
A December recall on Lay’s Potato Chips sold in two states has been escalated to the FDA’s highest risk level, but no allergic reactions have been reported.